Ok You Jung, Jung Sung-Ho, Lee Seung-Whan, Ahn Jung-Min, Lim Ju Yong
Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
J Thorac Dis. 2019 Mar;11(3):865-872. doi: 10.21037/jtd.2019.01.110.
Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) is used in various cardiogenic shocks. In severe myocardial dysfunction, left heart (LH) distension may occur and aggravate pulmonary edema. Despite the recent case reports on various venting catheter insertion methods for LH decompression, the necessity and efficacy of LH venting procedure are still controversial. Therefore, we focused on evaluating efficacy of LH venting catheter insertion for LH decompression.
In total, 373 patients received VA ECMO at our institution from May 2012 to January 2016. Of these, 25 patients underwent LH venting catheter insertion. Indication for the procedure included pulmonary congestion observed on chest radiogram, with arterial pulse pressure ≤10 mmHg. The control group comprised of 45 patients with peripheral VA ECMO having arterial pulse pressure ≤ for ≥24 hours during the same study period who did not undergo LH venting procedure. Finally, 70 patients were compared and analyzed.
Mean age of the patients was 52.6±17.1 years. The ECMO running time in each group was 7.2±7.1 days in the vent (-) group and 9.2±8.5 days in the vent (+) group. Successful weaning rate was higher in the LH vent (+) group (P=0.08). Moreover, LH venting catheter insertion was identified as a predictor of weaning success with marginal significance (OR =2.47; 95% CI: 0.90-6.72; P=0.07).
LH decompression by venting catheter insertion in patients on VA ECMO may be more effective and helpful for successful ECMO weaning than conventional medical management without survival benefit.
静脉-动脉(VA)体外膜肺氧合(ECMO)用于各种心源性休克。在严重心肌功能障碍时,可能会出现左心(LH)扩张并加重肺水肿。尽管最近有关于各种用于LH减压的排气导管插入方法的病例报告,但LH排气程序的必要性和有效性仍存在争议。因此,我们专注于评估LH排气导管插入用于LH减压的效果。
2012年5月至2016年1月期间,共有373例患者在我院接受VA ECMO治疗。其中,25例患者接受了LH排气导管插入。该操作的指征包括胸部X线片上观察到的肺充血,动脉脉压≤10 mmHg。对照组由45例在同一研究期间接受外周VA ECMO且动脉脉压≤的患者组成,这些患者在≥24小时内未接受LH排气程序。最后,对70例患者进行了比较和分析。
患者的平均年龄为52.6±17.1岁。排气(-)组每组的ECMO运行时间为7.2±7.1天,排气(+)组为9.2±8.5天。LH排气(+)组的成功撤机率更高(P = 0.08)。此外,LH排气导管插入被确定为撤机成功的预测因素,具有边缘显著性(OR = 2.47;95% CI:0.90 - 6.72;P = 0.07)。
对于接受VA ECMO的患者,通过插入排气导管进行LH减压可能比传统药物治疗更有效且有助于成功撤机ECMO,但对生存率无益处。